Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,869,571
  • Shares Outstanding, K 131,170
  • Annual Sales, $ 982,020 K
  • Annual Income, $ -416,280 K
  • EBIT $ -437 M
  • EBITDA $ -403 M
  • 60-Month Beta 1.67
  • Price/Sales 12.18
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 56.97% (-1.74%)
  • Historical Volatility 49.77%
  • IV Percentile 23%
  • IV Rank 16.94%
  • IV High 103.43% on 04/04/25
  • IV Low 47.50% on 08/13/25
  • Expected Move (DTE 9) 9.27 (10.52%)
  • Put/Call Vol Ratio 1.43
  • Today's Volume 158
  • Volume Avg (30-Day) 960
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 19,415
  • Open Int (30-Day) 19,396
  • Expected Range 78.77 to 97.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.75
  • Number of Estimates 4
  • High Estimate -0.68
  • Low Estimate -0.84
  • Prior Year -0.77
  • Growth Rate Est. (year over year) +2.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.55 +0.55%
on 03/11/26
113.78 -22.63%
on 02/20/26
-19.55 (-18.17%)
since 02/11/26
3-Month
87.55 +0.55%
on 03/11/26
120.74 -27.09%
on 01/22/26
-13.35 (-13.17%)
since 12/11/25
52-Week
36.36 +142.11%
on 05/23/25
120.74 -27.09%
on 01/22/26
+45.40 (+106.50%)
since 03/11/25

Most Recent Stories

More News
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

Strategic collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest’s vast network ...

GH : 88.03 (-2.72%)
1 Russell 2000 Stock on Our Watchlist and 2 We Question

1 Russell 2000 Stock on Our Watchlist and 2 We Question

GH : 88.03 (-2.72%)
SRCE : 67.46 (-0.01%)
GBTG : 5.57 (+1.09%)
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America

Shield Across America mobile screening tour launches during Colorectal Cancer Awareness Month to address nation’s dangerously low screening rates by bringing Shield blood test directly to Americans ...

GH : 88.03 (-2.72%)
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened

1 in 3 eligible Americans avoid colorectal cancer (CRC) screenings because traditional methods are viewed as unpleasant and inconvenient Guardant's FDA-approved...

GH : 88.03 (-2.72%)
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know

SOLV : 67.62 (+0.03%)
GH : 88.03 (-2.72%)
ALHC : 18.01 (-0.50%)
ANIP : 76.29 (+0.43%)
CLOV : 2.0200 (+1.51%)
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 23, 2026, the Compensation Committee of Guardant’s Board of Directors approved the granting...

GH : 88.03 (-2.72%)
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

GH : 88.03 (-2.72%)
OMCL : 37.48 (-3.87%)
PACB : 1.3500 (-1.46%)
ALGN : 174.81 (+3.18%)
QDEL : 18.02 (-6.63%)
Stocks Rally After Supreme Court Rejects President Trumps Tariffs

The S&P 500 Index ($SPX ) (SPY ) today is up +0.43%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. U.S. equities climbed on Friday...

APO : 106.10 (-1.91%)
ARES : 103.46 (-4.80%)
GH : 88.03 (-2.72%)
OWL : 9.02 (-4.65%)
$SPX : 6,775.80 (-0.08%)
AKAM : 106.47 (+1.89%)
LYV : 165.83 (+0.18%)
TPG : 40.68 (-3.67%)
RNG : 38.87 (-4.47%)
$IUXX : 24,965.01 (+0.03%)
ZNM26 : 111-220 (-0.27%)
QQQ : 607.69 (-0.01%)
Guardant Health: Q4 Earnings Snapshot

Guardant Health: Q4 Earnings Snapshot

GH : 88.03 (-2.72%)
Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales

Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales

GH : 88.03 (-2.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 92.32
2nd Resistance Point 91.27
1st Resistance Point 89.65
Last Price 88.03
1st Support Level 86.98
2nd Support Level 85.93
3rd Support Level 84.31

See More

52-Week High 120.74
Fibonacci 61.8% 88.51
Last Price 88.03
Fibonacci 50% 78.55
Fibonacci 38.2% 68.59
52-Week Low 36.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar